Klocker, E.V.; Barth, D.A.; Riedl, J.M.; Prinz, F.; Szkandera, J.; Schlick, K.; Kornprat, P.; Lackner, K.; Lindenmann, J.; Stöger, H.;
et al. Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients. Cancers 2020, 12, 1154.
https://doi.org/10.3390/cancers12051154
AMA Style
Klocker EV, Barth DA, Riedl JM, Prinz F, Szkandera J, Schlick K, Kornprat P, Lackner K, Lindenmann J, Stöger H,
et al. Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients. Cancers. 2020; 12(5):1154.
https://doi.org/10.3390/cancers12051154
Chicago/Turabian Style
Klocker, Eva Valentina, Dominik Andreas Barth, Jakob Michael Riedl, Felix Prinz, Joanna Szkandera, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Jörg Lindenmann, Herbert Stöger,
and et al. 2020. "Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients" Cancers 12, no. 5: 1154.
https://doi.org/10.3390/cancers12051154
APA Style
Klocker, E. V., Barth, D. A., Riedl, J. M., Prinz, F., Szkandera, J., Schlick, K., Kornprat, P., Lackner, K., Lindenmann, J., Stöger, H., Stotz, M., Gerger, A., & Pichler, M.
(2020). Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients. Cancers, 12(5), 1154.
https://doi.org/10.3390/cancers12051154
